A Study of GFH312 in Healthy Subjects

NCT04676711 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Toxicity
Healthy

Interventions

DRUG: GFH312
DRUG: Placebo

Sponsor

GenFleet Therapeutics (Australia) Pty Ltd.